MindBio Therapeutics (XCNQ:MBIO) Net Margin % : 17.71% (As of Mar. 2024)

View and export this data going back to 2023. Start your Free Trial

What is MindBio Therapeutics Net Margin %?

Net margin is calculated as Net Income divided by its Revenue. MindBio Therapeutics's Net Income for the three months ended in Mar. 2024 was C$0.07 Mil. MindBio Therapeutics's Revenue for the three months ended in Mar. 2024 was C$0.38 Mil. Therefore, MindBio Therapeutics's net margin for the quarter that ended in Mar. 2024 was 17.71%.

The historical rank and industry rank for MindBio Therapeutics's Net Margin % or its related term are showing as below:

XCNQ:MBIO' s Net Margin % Range Over the Past 10 Years
Min: -563.82 Med: 0 Max: 0
Current: -563.82

XCNQ:MBIO's Net Margin % is ranked worse than
66.54% of 1019 companies
in the Biotechnology industry
Industry Median: -151.78 vs XCNQ:MBIO: -563.82

MindBio Therapeutics Net Margin % Historical Data

The historical data trend for MindBio Therapeutics's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

MindBio Therapeutics Net Margin % Chart

MindBio Therapeutics Annual Data

Trend

Jun21

Jun22

Jun23

Net Margin %

MindBio Therapeutics Quarterly Data
	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Net Margin %	Get a 7-Day Free Trial					-	-	-	-20.34	17.71

Competitive Comparison of MindBio Therapeutics's Net Margin %

For the Biotechnology subindustry, MindBio Therapeutics's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

MindBio Therapeutics's Net Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, MindBio Therapeutics's Net Margin % distribution charts can be found below:

* The bar in red indicates where MindBio Therapeutics's Net Margin % falls into.

MindBio Therapeutics Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

MindBio Therapeutics's Net Margin for the fiscal year that ended in Jun. 2023 is calculated as

Net Margin	=	Net Income (A: Jun. 2023 )	/	Revenue (A: Jun. 2023 )
	=	-3.823	/	0
	=	%

MindBio Therapeutics's Net Margin for the quarter that ended in Mar. 2024 is calculated as

Net Margin	=	Net Income (Q: Mar. 2024 )	/	Revenue (Q: Mar. 2024 )
	=	0.068	/	0.384
	=	17.71 %

MindBio Therapeutics (XCNQ:MBIO) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.

MindBio Therapeutics Net Margin % Related Terms

Thank you for viewing the detailed overview of MindBio Therapeutics's Net Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

MindBio Therapeutics (XCNQ:MBIO) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » MindBio Therapeutics Corp (XCNQ:MBIO) » Definitions » Net Margin %

Comparable Companies

Traded in Other Exchanges

WF6:Germany

Address

91-97 William Street, Level 4, Melbourne, VIC, AUS, 3000

Website

https://www.mindbiotherapeutics.com

MindBio Therapeutics Corp is pioneering clinical studies into the microdosing of psychedelic medicines to treat a range of medical conditions such as depression, anxiety, PTSD, panic disorder, chronic pain and opiate addictions. Its clinical trials microdosing of psychedelic medicines provide hope for sufferers of mental health conditions with new emerging treatment alternatives. The company invests in clinical research to discover potential new treatment options and aims to create novel medicines and treatment regimes from breakthrough microdosing studies. Geographically, the activities of the company takes place in Australia.